Riptide Bioscience, Inc.
Vallejo, CA, US· latest recorded location
Riptide Bioscience, Inc. is named on 9 US grants and 13 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 9
- Published applications
- 13
- Inventors
- 12
- Granted in 2026 so far
- 1
- Most recent grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2016 | 1 | 2 |
| 2017 | 0 | 2 |
| 2018 | 3 | 0 |
| 2019 | 1 | 2 |
| 2020 | 1 | 2 |
| 2021 | 1 | 2 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Technology areas
Share of 22 documents
Recent patents
- Methods for modulating macrophage activity3 Mar 2026US 12,564,617 B2
- Antimicrobial peptides and methods of using the same8 Mar 2022US 11,266,712 B2
- Peptides having immunomodulatory properties19 Oct 2021US 11,147,854 B2
- Antimicrobial peptides and methods of using the same4 Feb 2020US 10,548,944 B1
- Peptides having immunomodulatory properties17 Sep 2019US 10,413,584 B1
- Methods for Modulating Macrophage Activity2 Jul 2026US 2026/0183362 A1
- CD206 Targeted Peptide Conjugates and Methods of Using the Same22 May 2025US 2025/0161505 A1
- Methods for Modulating Macrophage Activity3 Mar 2022US 2022/0062373 A1
- Peptides Having Immunomodulatory Properties30 Dec 2021US 2021/0401927 A1
- Peptides Having Anti-Inflammatory Properties18 Mar 2021US 2021/0077566 A1
Most cited
By later US patents
- Peptides having anti-inflammatory properties29US 9,492,499 B22016
- Peptide-based methods for treating pancreatic cancer6US 10,016,480 B22018
- Antimicrobial peptides and methods of use thereof5US 10,017,542 B22018
- Antimicrobial peptides and methods of using the same2US 10,548,944 B12020
- Peptides having anti-inflammatory properties1US 10,149,886 B22018